In endometrial cancer, HLA-DMB expression was primarily associated with wound healing, interferon-gamma dominant, inflammatory, and lymphocyte-depleted molecular subtypes, but less so with immunologically quiet and transforming growth factor-beta dominant subtypes (Figure 6A). The gene discussed is HLA-DMB; the disease is endometrial cancer.